Insight Molecular Diagnostics Inc. (IMDX) Operating margin 2020–2025
Insight Molecular Diagnostics Inc. (IMDX) operating margin by fiscal year — reported operating income divided by reported revenue.
-1260.8%FY2025 · since FY2020: -2443.3% → -1260.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1260.8% | +1984.4 pp |
| FY2024 | -3245.1% | -1572.7 pp |
| FY2023 | -1672.4% | +206.2 pp |
| FY2022 | -1878.6% | +565.7 pp |
| FY2021 | -2444.3% | -0.9 pp |
| FY2020 | -2443.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMDX financial trends
IMDX RevenueIMDX Net incomeIMDX Net marginIMDX Gross profitIMDX Gross marginIMDX Operating incomeIMDX Operating cash flowIMDX Free cash flowIMDX Capital expendituresIMDX Return on equityIMDX Stock buybacksIMDX Dividends paidIMDX Total assetsIMDX Total liabilitiesIMDX Shareholders’ equityIMDX overview →